Sylvie Froidevaux
Department of Research-ZLF
University Hospital and University Children's Hospital
University of Basel
Basel
Switzerland
Name/email consistency: high
- A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases. Froidevaux, S., Calame-Christe, M., Schuhmacher, J., Tanner, H., Saffrich, R., Henze, M., Eberle, A.N. J. Nucl. Med. (2004)
- DOTA alpha-melanocyte-stimulating hormone analogues for imaging metastatic melanoma lesions. Froidevaux, S., Calame-Christe, M., Sumanovski, L., Tanner, H., Eberle, A.N. Ann. N. Y. Acad. Sci. (2003)
- Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model. Froidevaux, S., Eberle, A.N., Christe, M., Sumanovski, L., Heppeler, A., Schmitt, J.S., Eisenwiener, K., Beglinger, C., Mäcke, H.R. Int. J. Cancer (2002)
- Somatostatin analogs and radiopeptides in cancer therapy. Froidevaux, S., Eberle, A.N. Biopolymers (2002)
- A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis. Froidevaux, S., Calame-Christe, M., Tanner, H., Sumanovski, L., Eberle, A.N. J. Nucl. Med. (2002)
- Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo. Froidevaux, S., Eberle, A.N. J. Recept. Signal Transduct. Res. (2002)
- Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy. Froidevaux, S., Heppeler, A., Eberle, A.N., Meier, A.M., Häusler, M., Beglinger, C., Béhé, M., Powell, P., Mäcke, H.R. Endocrinology (2000)